SpringWorks Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
SpringWorks Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • SpringWorks Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $6.78M, a 16.3% increase year-over-year.
  • SpringWorks Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $25.9M, a 50.8% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $22.9M, a 273% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $6.15M, a 1026% increase from 2021.
  • SpringWorks Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $546K, a 59.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $22.9M +$16.8M +273% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $6.15M +$5.6M +1026% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $546K -$809K -59.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $1.36M -$2.19M -61.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.55M +$2.87M +423% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $678K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.